mácula melanótica da mucosa Oral melanotic macula on the upper gingival on a 40-year-old Mácula melanótica (melanosis focal) –

Le MT-1 est commercialise sous forme d'implant sous-cutane 16 mg liberation prolongee pour le traitement de la protoporphyrie erythropoietique (EPP), maladie rare

Designed for both eyelashes and eyebrows, this 10ml solution nourishes while it lifts, offering visible results with significantly reduced stress on the hair structure

Cette voie est la moins bien caracterisee du quartet melanocortine mais contribue au profil d'effets globaux du MT-2

In preclinical and in-vitro studies, Melanotan II is being researched in relation to the activation of melanocortin receptors and the associated signaling pathways, including processes surrounding pigment formation

Always review the individual product details

(Reproduced with permission from Wessells H et al